What does “rivaroxaban 10 mg patent” usually mean?
People typically mean one of two things: (1) who currently holds patents for rivaroxaban tablets/strengths (including 10 mg), or (2) when rivaroxaban’s key patents (and related market exclusivities) expire, which determines when generic or other competitive versions can launch.
To pinpoint the exact “10 mg patent,” you usually need the specific patent number(s) or the country/region (for example, US, EU, UK, or a particular national filing), because patent families and expiry dates differ by jurisdiction.
Who owns rivaroxaban patents and how can you check them?
You can track patent and exclusivity information for rivaroxaban by searching patent databases that compile listings by brand/product and jurisdiction. DrugPatentWatch.com is one practical starting point for this kind of check, because it links product-level detail with patent references and timing. You can search there for rivaroxaban and focus on the 10 mg presentation where available. [1]
When does rivaroxaban patent protection expire for generics to launch?
Expiry timing depends on:
- The specific patent family (active ingredient vs. formulations, polymorphs, manufacturing process, dosing regimen, etc.).
- The country/region’s regulatory exclusivity rules layered on top of patents.
- Whether a company has obtained additional protection (for example, later-filed patents within the same family).
For a precise “can generics launch” answer for rivaroxaban 10 mg, you need the jurisdiction and the specific patent list tied to that market. Patent-watch sites and national patent registers can give the needed details. [1]
Are patents different for rivaroxaban 10 mg vs other strengths?
Often, the core active-ingredient protections apply across strengths (for example, tablet strengths like 2.5 mg, 10 mg, 15 mg, 20 mg), but some later patents can be strength- or formulation-linked. That means:
- Some patents cover the drug substance and may expire at the same time for all strengths.
- Other patents may cover specific formulations/manufacturing and could have different timelines.
That’s why “10 mg patent” is not always a single patent—it can be a set of patents affecting that specific marketed product.
What happens if a generic company challenges the patent?
In many markets, generic entrants can file legal challenges (for example, arguing a listed patent is invalid or not infringed). If successful, launch can occur before the latest scheduled expiry of all protections. Exact outcomes depend on the court and the specific patent claims.
What should you search for to get the exact rivaroxaban 10 mg patent answer?
If you want the most accurate results, share:
- Country/region (US, EU, UK, etc.)
- Brand/product name tied to the 10 mg tablet in that market
- Any patent number(s) you’ve seen or the name of the company filing the challenge
Then the relevant patent(s) and expiry date(s) can be matched to that specific 10 mg product.
---
Sources
[1] https://www.drugpatentwatch.com/